CONSILIAS
DEAD

Serial Number

79403310

Owner

TrakCel Limited

Filing Date

Jan 10, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CONSILIAS Trademark

Serial Number: 79403310

CONSILIAS is a trademark filed by TrakCel Limited on January 10, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

TrakCel Limited (3 trademarks)

10-11 Raleigh Walk,

Entity Type: 99

Trademark Details

Filing Date

January 10, 2024

Registration Date

Not Registered

Goods & Services

Supply chain management software for cell and gene therapy and advanced therapies; software integration for supply chain management; software including medical and science; data management software for clinical trials; software for chain of identity and chain of custody management; application software for cloud computing services; software for the purpose of business and maintenance; software databases for the purposes of recording storage and processing of data; data storage apparatus; reporting software; software; cloud-based and cloud server; interactive business and database software; databases; training software; software for product development; artificial intelligence for analysis and reporting; artificial intelligence for healthcare.

Electronic data processing services including the collection of data for business purposes relating to health care information; computer database management services; data management services; data collection; data collection services; collection of data; commercial data analysis.

Software licensing for cell and gene therapy orchestration solution; software licensing to schedule and plan pharmaceutical resources; licensing of databases; granting of software licences to users.

Non-downloadable computer software in the medical sector including for cell and gene therapy orchestration; software as a service (SaaS) for business purposes; software as a service for cell and gene therapy orchestration; software as a services to schedule and plan pharmaceutical resources; software platforms for health data storage; control and tracking of cell and gene therapy products; software maintenance services; software as a service for management; control and tracking of cell and gene therapy products; platform as a service for cell and gene therapy orchestration; platform as a service to schedule and plan pharmaceutical resources; platform as a service for management; data as a service; software development services; consulting services in the field of software as a service; software customisation services; software for the purposes of consultancy and repair; platform software for business purposes; electronic data storage including data logs; online data storage services for the purposes of archiving databases; design and development of systems for data input, output, processing, display and storage; development of operating system software; software as a service featuring software for deep learning; technology consultation in the field of artificial intelligence; data authentication via blockchain; data storage via blockchain; validation and integrity of data via blockchain.

Training in the operation and development of software systems; training relating to development in the field of cell and gene therapy; general training; training and further training consultancy; training sessions; training and instruction; personnel training; training courses; staff training services; business training.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 12, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 27, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 27, 2026 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sep 3, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 28, 2025 ABN2
REFUSAL PROCESSED BY IB
Mar 1, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 13, 2025 RFCS
REFUSAL PROCESSED BY MPU
Feb 13, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 7, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 6, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 5, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 4, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 29, 2024 REPR